Alti-Doxycycline en es it fr

Alti-Doxycycline Brand names, Alti-Doxycycline Analogs

Alti-Doxycycline Brand Names Mixture

  • No information avaliable

Alti-Doxycycline Chemical_Formula

C22H24N2O8

Alti-Doxycycline RX_link

http://www.rxlist.com/cgi/generic/doxycyc.htm

Alti-Doxycycline fda sheet

Alti-Doxycycline FDA

Alti-Doxycycline msds (material safety sheet)

Alti-Doxycycline MSDS

Alti-Doxycycline Synthesis Reference

C. R. Stephens et al.; J. Am. Chem. Soc. 80; 5324 (1958)

Alti-Doxycycline Molecular Weight

444.435 g/mol

Alti-Doxycycline Melting Point

201 oC

Alti-Doxycycline H2O Solubility

630 mg/L

Alti-Doxycycline State

Solid

Alti-Doxycycline LogP

-1.219

Alti-Doxycycline Dosage Forms

Tablet; Capsule; Gel; Liquid; Powder; Powder for solution

Alti-Doxycycline Indication

For the treatment of the following infections:Rocky mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox, and tick fevers caused by Rickettsiae, Chancroid caused by Haemophilus ducreyi, Uncomplicated gonorrhea caused by Neisseria gonorrhoeae, Respiratory tract infections caused by Mycoplasma pneumoniae or Streptococcus pneumoniae. Lymphogranuloma ve

Alti-Doxycycline Pharmacology

Doxycycline, a long-acting tetracycline derived from oxytetracycline, is used to inhibit bacterial protein synthesis and treat non-gonococcal urethritis and cervicitis, exacerbations of bronchitis in patients with COPD, and adult periodontitis.

Alti-Doxycycline Absorption

completely absorbed after oral administration

Alti-Doxycycline side effects and Toxicity

anorexia, nausea, diarrhoea, glossitis, dysphagia, enterocolitis and inflammatory lesions (with monilial overgrowth) in the anogenital region. skin reactions such as maculopapular and erythematous rashes, exfoliative dermatitis, photosensitivity, hypersensitivity reactions such as urticaria, angioneurotic oedema, anaphylaxis, anaphyl-actoid purpura, pericarditis, and exacerbation of systemic lupus erythematosus, benign intracranial hypertension in adults disappearing on discontinuation of the medicine, haematologic abnormalities such as haemolytic anaemia, thrombocytopenia, neutropenia, and eosinophilia. LD50=262 mg/kg(i.p. in rat)

Alti-Doxycycline Patient Information

Alti-Doxycycline Organisms Affected

Enteric bacteria and other eubacteria